Sign in

CIK 0001671858

  • Non-accelerated filer
  • Smaller reporting company

ARS Pharmaceuticals, Inc.

Sign in to watch
Ticker
SPRY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811489190
Phone
+1 858-771-9307
Business address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, CA, 92130
Former names
Silverback Therapeutics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2024-04-19 Lowenthal Richard E PRESIDENT AND CEO Exercise or conversion +69,444 $1.44 $100K 4,315,313
2024-04-19 Lowenthal Richard E PRESIDENT AND CEO Exercise or conversion · Stock Option (right to buy) −119,047 117,333
2024-04-19 Lowenthal Richard E PRESIDENT AND CEO Exercise or conversion · Stock Option (right to buy) −69,444 166,936
2024-04-16 Tanimoto Sarina CHIEF MEDICAL OFFICER Sale 10b5-1 −50,000 $9.28 $464K 1,647,447
2024-04-16 Tanimoto Sarina CHIEF MEDICAL OFFICER Sale 10b5-1 −50,000 $9.28 $464K 1,848,499
2024-04-16 Lowenthal Richard E PRESIDENT AND CEO Sale 10b5-1 −50,000 $9.28 $464K 1,647,447
2024-04-16 Lowenthal Richard E PRESIDENT AND CEO Sale 10b5-1 −50,000 $9.28 $464K 1,848,499
2024-04-09 Tanimoto Sarina CHIEF MEDICAL OFFICER Sale 10b5-1 −50,000 $9.28 $464K 1,646,494
2024-04-09 Tanimoto Sarina CHIEF MEDICAL OFFICER Sale 10b5-1 −50,000 $9.28 $464K 1,898,499
2024-04-09 Lowenthal Richard E PRESIDENT AND CEO Sale 10b5-1 −50,000 $9.28 $464K 1,646,494
2024-04-09 Lowenthal Richard E PRESIDENT AND CEO Sale 10b5-1 −50,000 $9.28 $464K 1,898,499
2024-03-27 RA CAPITAL MANAGEMENT, L.P. Director Purchase +505,954 $9.79 $5.0M 9,958,073
2024-03-26 RA CAPITAL MANAGEMENT, L.P. Director Purchase +457,745 $9.55 $4.4M 9,452,119
2024-03-25 RA CAPITAL MANAGEMENT, L.P. Director Purchase +437,600 $9.06 $4.0M 8,994,374
2024-03-25 Lowenthal Richard E PRESIDENT AND CEO Sale 10b5-1 −47,635 $9.12 $435K 1,697,447
2024-03-25 Lowenthal Richard E PRESIDENT AND CEO Sale 10b5-1 −47,632 $9.12 $435K 1,948,499
2024-03-25 Tanimoto Sarina CHIEF MEDICAL OFFICER Sale 10b5-1 −47,635 $9.12 $435K 1,697,447
2024-03-25 Tanimoto Sarina CHIEF MEDICAL OFFICER Sale 10b5-1 −47,632 $9.12 $435K 1,948,499
2024-03-22 Lowenthal Richard E PRESIDENT AND CEO Sale 10b5-1 −1,017 $9.03 $9K 1,745,082
2024-03-22 Lowenthal Richard E PRESIDENT AND CEO Sale 10b5-1 −1,326 $9.01 $12K 1,996,131

Page 17 of 31 · 602 trades